News

Scientists in the U.K. have created a liver-specific gene therapy that could potentially treat arthrogryposis renal dysfunction cholestasis (ARC) syndrome, a fatal childhood disease marked…

As many as 1 in 4 U.S. military veterans with the liver disease primary biliary cholangitis (PBC) may have irreversible liver scarring, or cirrhosis,…

A liver transplant with an uncle serving as a living donor successfully managed advanced progressive familial intrahepatic cholestasis type 2 (PFIC2) in a one-year-old…

With new support from the U.S. Food and Drug Administration (FDA), Galectin Therapeutics is preparing for a late-stage clinical trial to test its therapy…

Children hospitalized with Alagille syndrome commonly had narrowing in the branches of the pulmonary artery, which carries blood from the heart to the lungs,…

People in the European Union with acute hepatitis C virus (HCV) infections now have a new treatment option: Abbvie’s Maviret (glecaprevir/pibrentasvir). EU regulators have…

Various factors, including male sex and younger age, were associated with an increased risk of primary sclerosing cholangitis (PSC) recurrence after liver transplant, according…

Children with progressive familial intrahepatic cholestasis (PFIC) who carry mutations that completely eliminate a protein’s production are nearly three times more likely to require…

Survodutide, Boehringer Ingelheim’s investigational injectable therapy, significantly reduces liver fat and leads to clinically meaningful weight loss in obese or overweight people with metabolic…

Among people with chronic hepatitis D (CHD) infection, combination treatment regimens containing lonafarnib show benefits in easing disease burden and improving liver health. Specifically,…